BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

414 related articles for article (PubMed ID: 29109281)

  • 1. Peptidyl arginine deiminase immunization induces anticitrullinated protein antibodies in mice with particular MHC types.
    Arnoux F; Mariot C; Peen E; Lambert NC; Balandraud N; Roudier J; Auger I
    Proc Natl Acad Sci U S A; 2017 Nov; 114(47):E10169-E10177. PubMed ID: 29109281
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Peptidylarginine Deiminase Autoimmunity and the Development of Anti-Citrullinated Protein Antibody in Rheumatoid Arthritis: The Hapten-Carrier Model.
    Auger I; Balandraud N; Massy E; Hemon MF; Peen E; Arnoux F; Mariot C; Martin M; Lafforgue P; Busnel JM; Roudier J
    Arthritis Rheumatol; 2020 Jun; 72(6):903-911. PubMed ID: 31820586
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Do RA associated HLA-DR molecules bind citrullinated peptides or peptides from PAD4 to help the development of RA specific antibodies to citrullinated proteins?
    Balandraud N; Auger I; Roudier J
    J Autoimmun; 2021 Jan; 116():102542. PubMed ID: 32928608
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-citrullinated peptides as autoantigens in rheumatoid arthritis-relevance to treatment.
    Sakkas LI; Bogdanos DP; Katsiari C; Platsoucas CD
    Autoimmun Rev; 2014 Nov; 13(11):1114-20. PubMed ID: 25182207
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PAD2 immunization induces ACPA in wild-type and HLA-DR4 humanized mice.
    Hemon MF; Lambert NC; Roudier J; Auger I
    Eur J Immunol; 2022 Sep; 52(9):1464-1473. PubMed ID: 35712879
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PAD4 Immunization Triggers Anti-Citrullinated Peptide Antibodies in Normal Mice: Analysis With Peptide Arrays.
    Hemon MF; Lambert NC; Arnoux F; Roudier J; Auger I
    Front Immunol; 2022; 13():840035. PubMed ID: 35432329
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Presence and role of anti-citrullinated protein antibodies in experimental arthritis models.
    Cantaert T; Teitsma C; Tak PP; Baeten D
    Arthritis Rheum; 2013 Apr; 65(4):939-48. PubMed ID: 23280233
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High-Titer Rheumatoid Arthritis Antibodies Preferentially Bind Fibrinogen Citrullinated by Peptidylarginine Deiminase 4.
    Blachère NE; Parveen S; Frank MO; Dill BD; Molina H; Orange DE
    Arthritis Rheumatol; 2017 May; 69(5):986-995. PubMed ID: 28029744
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relative efficiencies of peptidylarginine deiminase 2 and 4 in generating target sites for anti-citrullinated protein antibodies in fibrinogen, alpha-enolase and histone H3.
    Damgaard D; Bawadekar M; Senolt L; Stensballe A; Shelef MA; Nielsen CH
    PLoS One; 2018; 13(8):e0203214. PubMed ID: 30161253
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of potential autoantigens in anti-CCP-positive and anti-CCP-negative rheumatoid arthritis using citrulline-specific protein arrays.
    Poulsen TBG; Damgaard D; Jørgensen MM; Senolt L; Blackburn JM; Nielsen CH; Stensballe A
    Sci Rep; 2021 Aug; 11(1):17300. PubMed ID: 34453079
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Microchimeric cells promote production of rheumatoid arthritis-specific autoantibodies.
    Hemon M; Giassi M; Ghaffar Y; Martin M; Roudier J; Auger I; Lambert NC
    J Autoimmun; 2024 Jun; 146():103238. PubMed ID: 38754239
    [TBL] [Abstract][Full Text] [Related]  

  • 12. How RA Associated HLA-DR Molecules Contribute to the Development of Antibodies to Citrullinated Proteins: The Hapten Carrier Model.
    Roudier J; Balandraud N; Auger I
    Front Immunol; 2022; 13():930112. PubMed ID: 35774784
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection of autoantibodies to citrullinated BiP in rheumatoid arthritis patients and pro-inflammatory role of citrullinated BiP in collagen-induced arthritis.
    Shoda H; Fujio K; Shibuya M; Okamura T; Sumitomo S; Okamoto A; Sawada T; Yamamoto K
    Arthritis Res Ther; 2011; 13(6):R191. PubMed ID: 22108001
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Citrullination of synovial proteins in murine models of rheumatoid arthritis.
    Vossenaar ER; Nijenhuis S; Helsen MM; van der Heijden A; Senshu T; van den Berg WB; van Venrooij WJ; Joosten LA
    Arthritis Rheum; 2003 Sep; 48(9):2489-500. PubMed ID: 13130468
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protein Citrullination by Peptidyl Arginine Deiminase/Arginine Deiminase Homologs in Members of the Human Microbiota and Its Recognition by Anti-Citrullinated Protein Antibodies.
    Pérez-Pérez ME; Nieto-Torres E; Bollain-Y-Goytia JJ; Delgadillo-Ruíz L
    Int J Mol Sci; 2024 May; 25(10):. PubMed ID: 38791230
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Periodontal sources of citrullinated antigens and TLR agonists related to RA.
    Vitkov L; Hannig M; Minnich B; Herrmann M
    Autoimmunity; 2018 Sep; 51(6):304-309. PubMed ID: 30417696
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Citrullination of self-proteins and autoimmunity.
    Rubin B; Sønderstrup G
    Scand J Immunol; 2004; 60(1-2):112-20. PubMed ID: 15238080
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rheumatoid arthritis-specific autoantibodies to peptidyl arginine deiminase type 4 inhibit citrullination of fibrinogen.
    Auger I; Martin M; Balandraud N; Roudier J
    Arthritis Rheum; 2010 Jan; 62(1):126-31. PubMed ID: 20039406
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of citrullinated vimentin peptides as T cell epitopes in HLA-DR4-positive patients with rheumatoid arthritis.
    Feitsma AL; van der Voort EI; Franken KL; el Bannoudi H; Elferink BG; Drijfhout JW; Huizinga TW; de Vries RR; Toes RE; Ioan-Facsinay A
    Arthritis Rheum; 2010 Jan; 62(1):117-25. PubMed ID: 20039411
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential ACPA Binding to Nuclear Antigens Reveals a PAD-Independent Pathway and a Distinct Subset of Acetylation Cross-Reactive Autoantibodies in Rheumatoid Arthritis.
    Lloyd KA; Wigerblad G; Sahlström P; Garimella MG; Chemin K; Steen J; Titcombe PJ; Marklein B; Zhou D; Stålesen R; Ossipova E; Lundqvist C; Ekwall O; Rönnelid J; Mueller DL; Karlsson MCI; Kaplan MJ; Skriner K; Klareskog L; Wermeling F; Malmström V; Grönwall C
    Front Immunol; 2018; 9():3033. PubMed ID: 30662440
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.